P04.12 Billable / specific Newborn affected by maternal cytotoxic drugs

ICD-10-CM P04.12 identifies “Newborn affected by maternal cytotoxic drugs” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 16: Certain conditions originating in the perinatal period

Code-level instructions

No additional notes.

Inherited instructions

P04 · Newborn affected by noxious substances transmitted via placenta or breast milk

Includes1

nonteratogenic effects of substances transmitted via placenta

Excludes 24
  • congenital malformations (Q00-Q99)
  • encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
  • neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
  • newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Code first1

any current condition in newborn, if applicable

P04.1 · Newborn affected by other maternal medication

Excludes 12
  • dysmorphism due to warfarin (Q86.2)
  • fetal hydantoin syndrome (Q86.1)
Excludes 22
  • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
  • maternal use of drugs of addiction (P04.4-)
Code first2
  • , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
  • withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

Chapters 16 · Certain conditions originating in the perinatal period (P00-P96)

Includes1

conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later

Excludes 25
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • tetanus neonatorum (A33)
Note1

Codes from this chapter are for use on newborn records only, never on maternal records

P00-P04 · Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)

Note1

These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).

Official index references

Official index references (1)

Newborn(infant) (liveborn) (singleton) (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2018-10-01

Previous assignment: P04.1

History

Code history

Latest recorded change · FY2024

ChangedUnchanged
FY2024

Effective from

  • Inherited rules changed

Newborn affected by maternal cytotoxic drugs

Billable diagnosis code

CDC/NCHS · FY2024

All editions (16)

All editionsEffective fromCode history
FY20192018-10-01Added
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01Inherited rules changed
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01Inherited rules changed
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.